OR WAIT null SECS
April 02, 2011
An uncertain regulatory environment affects funding for biotechnology.
April 01, 2011
This technical forum is part of a special issue on Solid Dosage and Excipients.
The author explains how to gain an understanding of the relationships between powder characteristics and process performance to match filling-machine geometry to the demands of specific formulations.
The author focuses on how industry can build a system for Total Excipient Control.
Representatives from Pfizer R&D, DEM Solutions, Colorcon, and ARmark Authentication Technologies provide insight into recent tablet-coating technologies.
The author describes key considertions for a complete risk-assessment model and provides insight into a pending IPEC guideline in this area.
Nanotechnology often is associated with parenteral drug delivery, particularly for anticancer therapies, but it also has applications in oral drug delivery
The authors examine an oral-absorption-enhancement technology based on surface-active materials to increase apical membrane fluidity in vitro.
March 31, 2011
The National Institutes of Health?s (NIH) definition of embryonic stem (ES) cells poses new challenges for investigators who seek federal research funding.
March 03, 2011
Pfizer Completes King Acquisition; ViiV Healthcare Names Chairman; and More.